The global Orthopedic Biomaterials Market size is expected to reach USD 35.90 billion by 2030, growing at a CAGR of 7.5% from 2024 to 2030, according to a new study by Grand
View Research, Inc. Several key factors, including the increasing prevalence of
orthopedic conditions and advancements in biomaterial technology, drive the
market. Due to an aging population and active lifestyles, the rising incidence
of musculoskeletal disorders, such as osteoarthritis and fractures, is
significantly boosting the demand for orthopedic biomaterials. Moreover,
technological innovations, such as the development of advanced composites and
smart biomaterials, enhance the performance and integration of these materials
in orthopedic implants and prosthetics, thereby expanding their application and
effectiveness.
The increasing
prevalence of musculoskeletal disorders and chronic skeletal conditions is
fueling the market growth. According to the 2023 HSE Report, approximately
473,000 workers in Great Britain experienced work-related musculoskeletal
disorders (MSDs), resulting in the loss of around 6.6 million working days.
These disorders accounted for 27% of all work-related ill health cases. The
growing focus on minimally invasive surgical techniques also contributes to
market growth. Orthopedic biomaterials that support less invasive procedures,
such as bioresorbable materials and improved implant coatings, are gaining
traction due to their potential to reduce recovery times and complications. The
increased investment in research and development, rising healthcare
expenditures, and awareness about advanced orthopedic solutions further propels
the market, making it a dynamic and rapidly evolving sector.
The rising
prevalence of trauma cases is also driving the demand for orthopedic
biomaterials. According to an article published by WHO in June 2022, road
accidents kill approximately 1.3 million people worldwide, and approximately 20
to 50 million people suffer from non-fatal injuries. These injuries often
require orthopedic surgery, leading to an increased demand for orthopedic
biomaterials.
List of Key
Players in the Orthopedic Biomaterials Market
- DSM Biomedical
- Evonik industries AG
- Stryker Corp.
- Depuy Synthes Inc.
- Zimmer Biomet
- Invibo Ltd.
- Globus Medical
- Exactech, Inc.
- Matexcel
- AdvanSource
- Biomaterials Corp.
- CAM Bioceramics B.V.
- Heraeus Holding
Related Press Release@ Orthopedic Biomaterials Market Report
Orthopedic
Biomaterials Market Report Highlights
- By material, ceramics & bioactive glass segment
accounted for the highest revenue share in 2023. The growth is attributed
to the increased adoption of ceramics in the repair of hard tissues in
various procedures
- By application, orthopedic implants segment
accounted for the largest market share in 2023. The growth is owed to the
rising incidences of disc degenerative conditions and bone fractures coupled
with increasing trauma case
- In 2023, North America dominated the overall market
with a revenue share of 36.2% due to the rising adoption of advanced
products for bone void filling and implant load-bearing purposes
Orthopedic Biomaterials Market
Report Scope
|
Report Attribute |
Details |
|
Market
size value in 2024 |
USD 23.30
billion |
|
Revenue
forecast in 2030 |
USD 35.90
billion |
|
Growth
rate |
CAGR of
7.5% from 2024 to 2030 |
|
Actual
data |
2018 - 2023 |
|
Forecast data |
2024 - 2030 |
Orthopedic
Biomaterials Market Segmentation
Grand View
Research has segmented the global orthopedic biomaterials market based on
material, application, and region:
Orthopedic
Biomaterials Material Outlook (Revenue, USD Million, 2018 - 2030)
- Ceramics & Bioactive Glass Biomaterials
- Polymers Biomaterials
- Calcium Phosphate Cements
- Metal Biomaterials
- Composites
Orthopedic
Biomaterials Application Outlook (Revenue, USD Million, 2018 - 2030)
- Orthopedic Implants
- Joint Replacement/reconstruction
- Orthobiologics
- Visco Supplementation
- Bio-resorbable Tissue Fixation
Orthopedic
Biomaterials Regional Outlook (Revenue, USD Million, 2018 - 2030)
- North America
- U.S.
- Canada
- Mexico
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Norway
- Sweden
- Denmark
- Asia Pacific
- Japan
- China
- India
- Australia
- South Korea
- Thailand
- Latin America
- Brazil
- Argentina
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Kuwait
Explore Horizon, the world's most expansive market
research database
About Us:
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco. The
company provides syndicated research reports, customized research reports, and
consulting services. To help clients make informed business decisions, the
company offers market intelligence studies ensuring relevant and fact-based
research across a range of industries including technology, chemicals,
materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com
No comments:
Post a Comment